We expect this review will enhance the understanding of the critical role of PAD4 in cancer progression and immunotherapy as well as provide an open perspective for the development of next-generation PAD4 inhibitors with dual functions of antitumor activity and antitumor immunity. The gene discussed is PADI4; the disease is cancer.